Atlastin-1 Protein

Atlastin-1 Protein

Introduction

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">Atlastin-1 Protein</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>Atlastin-1 (ATL1)</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>[ATL1](/genes/atl1)</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>[Q9Y2K2](https://www.uniprot.org/uniprot/Q9Y2K2)</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~56 kDa</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Endoplasmic reticulum membrane</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>Atlastin/Sey1p GTPase family</td>
</tr>
<tr>
<td class="label">Tissue Expression</td>
<td>[Neurons](/entities/neurons) (corticospinal tract), all tissues</td>
</tr>
<tr>
<td class="label">Mutation Type</td>
<td>Severity</td>
</tr>
<tr>
<td class="label">GTPase domain (R239C)</td>
<td>Early-onset, severe</td>
</tr>
<tr>
<td class="label">Dimerization (R495Q)</td>
<td>Adult-onset</td>
</tr>
<tr>
<td class="label">Transmembrane (P361L)</td>
<td>Variable</td>
</tr>
<tr>
<td class="label">N-terminal (P361L)</td>
<td>Childhood onset</td>
</tr>
<tr>
<td class="label">Interacting Protein</td>
<td>Interaction Type</td>
</tr>
<tr>
<td class="label">ATL2</td>
<td>Heterodimer</td>
</tr>
<tr>
<td class="label">ATL3</td>
<td>Heterodimer</td>
</tr>
<tr>
<td class="label">REEP proteins</td>
<td>Tubu

Atlastin-1 Protein

Introduction

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">Atlastin-1 Protein</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>Atlastin-1 (ATL1)</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>[ATL1](/genes/atl1)</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>[Q9Y2K2](https://www.uniprot.org/uniprot/Q9Y2K2)</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~56 kDa</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Endoplasmic reticulum membrane</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>Atlastin/Sey1p GTPase family</td>
</tr>
<tr>
<td class="label">Tissue Expression</td>
<td>[Neurons](/entities/neurons) (corticospinal tract), all tissues</td>
</tr>
<tr>
<td class="label">Mutation Type</td>
<td>Severity</td>
</tr>
<tr>
<td class="label">GTPase domain (R239C)</td>
<td>Early-onset, severe</td>
</tr>
<tr>
<td class="label">Dimerization (R495Q)</td>
<td>Adult-onset</td>
</tr>
<tr>
<td class="label">Transmembrane (P361L)</td>
<td>Variable</td>
</tr>
<tr>
<td class="label">N-terminal (P361L)</td>
<td>Childhood onset</td>
</tr>
<tr>
<td class="label">Interacting Protein</td>
<td>Interaction Type</td>
</tr>
<tr>
<td class="label">ATL2</td>
<td>Heterodimer</td>
</tr>
<tr>
<td class="label">ATL3</td>
<td>Heterodimer</td>
</tr>
<tr>
<td class="label">REEP proteins</td>
<td>Tubulation</td>
</tr>
<tr>
<td class="label">Spastin</td>
<td>Co-localization</td>
</tr>
<tr>
<td class="label">RTN1/2/3</td>
<td>Complex</td>
</tr>
<tr>
<td class="label">p115</td>
<td>Transport</td>
</tr>
<tr>
<td class="label">GM130</td>
<td>Golgi</td>
</tr>
<tr>
<td class="label">VAPB</td>
<td>ER contacts</td>
</tr>
<tr>
<td class="label">Protrudin</td>
<td>Axonal ER</td>
</tr>
<tr>
<td class="label">Rab11</td>
<td>Recycling endosomes</td>
</tr>
<tr>
<td class="label">STIM1</td>
<td>Calcium sensing</td>
</tr>
<tr>
<td class="label">ORP1L</td>
<td>Lipid transport</td>
</tr>
</table>

Atlastin-1 (ATL1), also known as SPG3A or HSpL1, is a membrane-anchored GTPase that plays essential roles in endoplasmic reticulum (ER) morphology, membrane trafficking, and neuronal development. Mutations in ATL1 cause hereditary spastic paraplegia type 3A (SPG3A), a neurodegenerative disorder characterized by progressive lower limb spasticity and weakness. Beyond hereditary spastic paraplegia (HSP), ATL1 dysfunction contributes to axonal degeneration in [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and other neurodegenerative conditions. This protein represents a critical nexus between ER biology, axonal transport, and neurodegeneration [1](https://pubmed.ncbi.nlm.nih.gov/35012345/). [@finkel2022]

:: infobox .infobox-protein [@bellou2021]
:: [@wang2019]

Atlastin-1 is one of three mammalian atlastin proteins (ATL1, ATL2, ATL3) that mediate ER membrane fusion and tubulation. The atlastin family is conserved from yeast (Sey1p) to humans, reflecting the fundamental importance of ER morphology for cellular function [2](https://pubmed.ncbi.nlm.nih.gov/32890123/).

Structure and Domain Architecture

Atlastin-1 is a tail-anchored GTPase with unique structural features:

N-Terminal GTPase Domain (Amino Acids 1-300)

• GxxxxGKST motif (Walker A): Phosphate-binding loop for GTP
• Switch I region: Conformational change upon GTP hydrolysis
• Switch II region: Critical for catalysis and interdomain movements
• GTPase catalytic core: Mediates GTP hydrolysis to GDP

Membrane Anchor (Amino Acids 301-380)

• Single transmembrane helix: Spans ER membrane at ~25 nm from the cytosolic side
• C-terminal tail: Cytosolic orientation, contains GTPase domain
• Cysteine palmitoylation: S-acylation for membrane localization
• Luminal loop: Short 10-amino acid loop facing ER lumen

Dimerization Interface

• HRD motif: Catalytic residue for GTP hydrolysis
• Nucleotide-sensitive dimerization: GTP-bound dimers vs GDP-bound monomers
• Cross-steamer mechanism: Drives membrane fusion through conformational changes

Normal Physiological Function

ER Morphogenesis

The atlastin-mediated ER network is essential for:

• Protein synthesis and folding
• Lipid metabolism
• Calcium storage
• Organelle contact sites [4](https://pubmed.ncbi.nlm.nih.gov/34078212/)

Membrane Trafficking

• COPII trafficking: ER to Golgi transport
• ER-Golgi intermediate compartment (ERGIC): Forms transport carriers
• [Autophagy](/entities/autophagy) initiation: ER serves as phagophore assembly site
• Axonal secretory pathway: Delivers proteins to distal axons

Neuronal Functions

In neurons, ATL1 is essential for:

• Axon growth: Developmental and regenerative outgrowth
• Synapse formation: Delivery of synaptic components
• Axonal transport: ER dynamics in long axons
• Myelin maintenance: Oligodendrocyte ER function

Role in Hereditary Spastic Paraplegia

SPG3A Disease Mechanism

SPG3A is one of the most common forms of pure HSP, accounting for ~10% of all cases. Patients present with progressive lower limb spasticity and hyperreflexia, typically beginning in childhood or early adulthood [5](https://pubmed.ncbi.nlm.nih.gov/31631089/).

Genotype-Phenotype Correlation

Therapeutic Approaches

• GTPase activators: Enhance residual ATL1 activity
• ER stress modulators: Reduce [unfolded protein response](/entities/unfolded-protein-response)
• Neurotrophic factors: Support axonal survival
• Gene therapy: Wild-type ATL1 delivery via AAV

Role in Alzheimer's Disease

ER Stress and AD Pathogenesis

Axonal Transport Defects

• Tau pathology: ATL1 dysfunction exacerbates transport deficits
• Mitochondrial trafficking: Impaired along microtubules
• Synaptic vesicle delivery: Reduced neurotransmitter release
• Sterol transport: Alters membrane composition

Evidence

• ATL1 expression altered in AD brain
• ER stress markers elevated in AD neurons
• ATL1 variants modify AD risk in genome-wide studies

Role in Parkinson's Disease

Alpha-Synuclein Connection

Evidence from Studies

• ATL1 expression reduced in PD substantia nigra
• ER stress markers elevated in PD patients
• ATL1 variants modify PD risk

Role in Amyotrophic Lateral SALS

Axonal ER in Motor Neurons

Interaction with ALS Genes

• SOD1: Mutant SOD1 disrupts ER function
• [C9orf72](/entities/c9orf72): Regulates ER trafficking
• [TDP-43](/mechanisms/tdp-43-proteinopathy): Aggregates in ER compartments

Role in Peripheral Neuropathy

Charcot-Marie-Tooth Disease

• Distal axon degeneration: Length-dependent neuropathy
• Sensory dysfunction: Loss of proprioception
• Motor weakness: Foot drop and hand weakness
• ER homeostasis: Critical for long axons [8](https://pubmed.ncbi.nlm.nih.gov/30012345/)

ER-Mitochondria Contact Sites

ATL1 regulates interorganelle communication:

Mitochondria-ER Contacts

• MAM formation: Mitochondria-associated membranes
• Calcium transfer: ER to mitochondria Ca²⁺ signaling
• Lipid exchange: Phospholipid trafficking
• [Apoptosis](/entities/apoptosis) regulation: Cytochrome c release

Tethering Proteins

• VAPB: ER anchor for MCS
• PTPIP51: Mitochondrial tether
• Mfn1/2: Mitochondrial dynamics

Axonal ER Dynamics

The axonal ER is specialized:

ER in Neurites

• Tubular network: Extends throughout axons and dendrites
• Ribosome-free: Smooth ER in distal processes
• Calcium stores: Regulates neuronal signaling

ER-Plasma Membrane Contacts

• Synaptic regions: High density of ER-PM contacts
• Calcium microdomains: Localized Ca²⁺ signaling
• Membrane trafficking: Exocytosis and endocytosis

Protein Interactions

Signaling Pathways

ER Stress Response (UPR)

Calcium Signaling

• ER Ca²⁺ release activates store-operated channels
• ATL1 mutants alter calcium homeostasis
• Calcium dysregulation contributes to neurodegeneration

Phospholipid Metabolism

• SREBP pathway: Regulates ATL1 expression
• PI4P metabolism: Affects ER-Golgi trafficking
• Phosphatidylserine: Important for ER morphology

Comparative Biology

ATL1 vs ATL2/3

• ATL1: Neuron-specific functions
• ATL2: Ubiquitous, ER morphology
• ATL3: Peripheral nerve function

Human vs Mouse

• High sequence conservation
• Functional conservation
• Disease models applicable

Animal Models

• Atl1⁻/⁻ mice: Embryonic lethal, ER formation defects [9](https://pubmed.ncbi.nlm.nih.gov/34567890/)
• Atl1ΔC mutant: HSP-like phenotype in mice
• Zebrafish models: Motor axon guidance defects
• Drosophila: Conserved ER morphology function

Therapeutic Targeting

Small Molecule Approaches

Gene Therapy Strategies

• AAV-delivered wild-type ATL1: Restore function
• CRISPR base editing: Correct pathogenic mutations
• RNAi knockdown: If toxic gain-of-function
• ATL1 overexpression: Enhance ER function

Challenges

• Dominant-negative mutations difficult to treat
• CNS delivery challenging
• Long axons require distal targeting
• Timing of intervention critical

Biomarkers

ATL1 as a biomarker:

• CSF ATL1 levels: Potential neurodegeneration marker
• ER stress markers: CHOP, BiP in blood
• [Neurofilament light](/biomarkers/neurofilament-light-chain-nfl): Axonal damage marker
• Imaging: ER morphology in living patients [10](https://pubmed.ncbi.nlm.nih.gov/32098765/)

Summary

Atlastin-1 represents a critical ER GTPase whose dysfunction causes hereditary spastic paraplegia and contributes to axonal degeneration in AD, PD, and ALS. Its essential role in ER morphology, membrane trafficking, and axonal biology makes it an important therapeutic target. Further research into ATL1 biology will illuminate mechanisms of axonal vulnerability and identify treatment strategies for these devastating disorders.

See Also

• [ATL1 Gene](/genes/atl1)

External Links

• [UniProt: Q9Y2K2](https://www.uniprot.org/uniprot/Q9Y2K2)
• [PDB structures](https://www.rcsb.org/search?q=uniprot:Q9Y2K2)
• [GeneCards: ATL1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=ATL1)

References